Cellular-Membrane-Derived Vesicles for Cancer Immunotherapy
Open Access
- 22 December 2023
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (1) , 22
Abstract
The medical community is constantly searching for new and innovative ways to treat cancer, and cellular-membrane-derived artificial vesicles are emerging as a promising avenue for cancer immunotherapy. These vesicles, which are derived from mammal and bacteria cell membranes, offer a range of benefits, including compatibility with living organisms, minimal immune response, and prolonged circulation. By modifying their surface, manipulating their genes, combining them with other substances, stimulating them externally, and even enclosing drugs within them, cellular vesicles have the potential to be a powerful tool in fighting cancer. The ability to merge drugs with diverse compositions and functionalities in a localized area is particularly exciting, as it offers a way to combine different immunotherapy treatments for maximum impact. This review contains information on the various sources of these vesicles and discusses some recent developments in cancer immunotherapy using this promising technology. While there are still obstacles to overcome, the possibilities for cellular vesicles in cancer treatment are truly exciting.Keywords
Funding Information
- National Natural Science Foundation of China (81925019, U22A20333, 82272144, 2020A1515110456, 2022J011403, 2020Y4003, JCYJ20220530143411025, JCYJ20230807091404010)
- Guangdong Basic and Applied Basic Research Foundation (81925019, U22A20333, 82272144, 2020A1515110456, 2022J011403, 2020Y4003, JCYJ20220530143411025, JCYJ20230807091404010)
- Shenzhen Science and Technology Innovation Commission (81925019, U22A20333, 82272144, 2020A1515110456, 2022J011403, 2020Y4003, JCYJ20220530143411025, JCYJ20230807091404010)
This publication has 92 references indexed in Scilit:
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer TherapyCancer Cell, 2015
- Cancer Immunotherapy2013
- Neutrophil recruitment and function in health and inflammationNature Reviews Immunology, 2013
- Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functionsNature Nanotechnology, 2012
- Presentation of Phagocytosed Antigens by MHC Class I and IITraffic, 2012
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic MelanomaCancer Research, 2012
- Delivery of foreign antigens by engineered outer membrane vesicle vaccinesProceedings of the National Academy of Sciences, 2010
- Functions of natural killer cellsNature Immunology, 2008
- Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimuriumProceedings of the National Academy of Sciences, 2005
- Carrier Erythrocytes: An OverviewDrug Delivery, 2003